Clinical Center logo NIH Clinical Center National Institutes of Health
    America's Clinical Research Hospital File folder iconExplore the NIH
Clinical Center
Search the Studies - NIH Clinical Research Studies

Protocol Details

Determining the Pathogenesis of Systemic Pediatric-Onset Mastocytosis

This study is currently recruiting participants.

Summary | Eligibility | Citations | Contacts

Summary

Number

03-I-0041

Sponsoring Institute

National Institute of Allergy and Infectious Diseases (NIAID)

Recruitment Detail

Type: Participants currently recruited/enrolled
Gender: Male & Female
Min Age: 0
Max Age: 21

Referral Letter Required

Yes

Population Exclusion(s)

None

Special Instructions

Currently Not Provided

Keywords

Children;
Mast Cells;
Urticaria Pigmentosa;
Bone Marrow;
Severe

Recruitment Keyword(s)

Mastocytosis;
Pediatric Mastocytosis

Condition(s)

Mastocytosis

Investigational Drug(s)

None

Investigational Device(s)

None

Intervention(s)

None

Supporting Site

National Institute of Allergy and Infectious Diseases

This study will evaluate children with mastocytosis, a disease of excessive mast cells in tissues such as skin and bone marrow, to identify the cause of the disease and describe its course. Mast cells can release chemicals that cause itching, blisters, flushing, bone pain, and abdominal pain. Usually, mastocytosis in children involves the skin only and is of limited duration. This study, however, will focus on children with more severe disease that more closely resembles adult-onset mastocytosis.

Patients up to 21 years of age with childhood-onset mastocytosis may be eligible for this study. Candidates must have one or more of the following abnormalities, which indicate severe disease: enlarged liver or spleen; diffuse skin involvement; history of gastrointestinal bleeding or peptic ulcer; bone marrow biopsy with abnormal mast cells either in number or shape; elevated blood levels of the enzyme tryptase; or abnormal hemoglobin, white blood cells, platelets, or clotting factors.

Participants will have a medical history and physical examination; various blood tests, including studies to identify genetic changes that are important in the growth, development, and functioning of human mast cells; and bone marrow aspiration and biopsy. For the bone marrow procedure, the skin over the hipbone and the outer surface of the bone itself are numbed with an injection of local anesthesia. Then, a special needle is inserted into the hipbone and about 2 tablespoons of bone marrow are drawn into a syringe. Another needle is then inserted through the first needle to collect a small piece of the bone marrow. Pain will be managed according to the individual patient's needs. Additional procedures, such as a gastroenterology consultation, colonoscopy to examine the colon, or computerized axial tomography (CT) or ultrasound of the abdomen to assess the liver and spleen, may be done if medically indicated. Standard medical treatment, including antihistamines for itching or steroids for abdominal cramping or diarrhea, will be recommended as appropriate.

Patients' biologic parents may also be enrolled to provide a blood sample for genetic analysis and a bone marrow aspirate and biopsy for clinical and research purposes.

Patients will return to NIH once a year for follow-up evaluations until their disease is stable or until the 5-year study ends.

--Back to Top--

Eligibility

INCLUSION CRITERIA:

Children with tissue-diagnosed pediatric-onset mastocytosis formerly enrolled in protocols 90-I-0120, and 93-I-0136 or per physician referral with more severe disease as indicated by one of the following parameters:

-Hepatomegaly or splenomegaly;

-Diffuse cutaneous mastocytosis;

-History of gastrointestinal bleeding or peptic ulcer disease;

-Bone marrow biopsy with abnormal numbers or shaped mast cells or abnormal flow cytometry;

-Serum tryptase greater than 20ng/ml;

-Hematologic abnormalities such as an increase WBC, thrombocytosis, and/or an increase in PT and/or PTT.

INCLUSION CRITERIA-SUBJECT:

-Age birth to 21.0 years of age at the time of entry into the protocol

-Diagnosis of mastocytosis by skin examination or histologic evidence in a skin or bone marrow biopsy

-Subject has a primary medical care provider outside the NIH

-Subject or parent or guardian is able to give informed consent

INCLUSION CRITERIA-PARENT:

-A child with the diagnosis of mastocytosis by skin examination or histologic evidence in a skin or bone marrow biopsy

-Subject has a primary medical care provider outside the NIH

EXCLUSION CRITERIA - SUBJECT:

-Age greater than or equal to 21.0 years

-No primary care physician

-Has AIDS or is HIV Positive


--Back to Top--

Citations:

Kettelhut BV, Metcalfe DD. Pediatric mastocytosis. Ann Allergy. 1994 Sep;73(3):197-202; quiz 202-7.

Kirshenbaum AS, Goff JP, Kessler SW, Mican JM, Zsebo KM, Metcalfe DD. Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells. J Immunol. 1992 Feb 1;148(3):772-7.

Dvorak AM, Seder RA, Paul WE, Morgan ES, Galli SJ. Effects of interleukin-3 with or without the c-kit ligand, stem cell factor, on the survival and cytoplasmic granule formation of mouse basophils and mast cells in vitro. Am J Pathol. 1994 Jan;144(1):160-70.

--Back to Top--

Contacts:

Principal Investigator

Referral Contact

For more information http://clinicalstudies.info.nih.gov.

Melody C. Carter, M.D.
National Human Genome Research Institute (NHGRI)
333 Cassell Drive
Suite 1200
Baltimore, MD 21224
(443) 740-2921
jebw@nhgri.nih.gov

Linda M. Scott, C.R.N.P.
National Human Genome Research Institute (NHGRI)
333 Cassell Drive
Suite 1200
Baltimore, MD 21224
(443) 740-2921
jebw@nhgri.nih.gov

Patient Recruitment and Public Liaison Office
Building 61
10 Cloister Court
Bethesda, Maryland 20892-4754
Toll Free: 1-800-411-1222
TTY: 301-594-9774 (local),1-866-411-1010 (toll free)
Fax: 301-480-9793

prpl@mail.cc.nih.gov

Clinical Trials Number:

NCT00050193

--Back to Top--

QUESTIONS?

Contact the Patient Recruitment and Public Liaison Office for:

  • Details on how to participate in a study
  • Details on how to refer a patient to a study

NIH Clinical Studies Information Request


Contact the Office of Communications for:

  • General information about the NIH Clinical Center

www.cc.nih.gov/contact.shtml


Contact the Department Clinical Research Informatics, (DCRI) for:

  • Technical questions about Adobe Acrobat and the PDF format
  • Technical questions about this web server

webmaster@cc.nih.gov